GSK to buy Boston-based IDRx for $1.15 billion
GSK (NYSE:GSK) finalized the deal to acquire Boston-based, clinical-stage biopharmaceutical company—IDRx for a total of up to ...
Celtics Trade Proposal Lands $15M Wing From West Contender
The Boston Celtics are one of the best teams in the NBA. They have a great chance to repeat as NBA Champions, but the future has some questions. This trade proposal would have them fix that problem ...